Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ACHR vs MRNA✓SelectedUSD · MRNAACHR vs MRNA performance historyLatest closeAs of-9.06%11/20
Stock and ETF performance explorer

ACHR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-57.6%
MRNA return
+697.5%
Excess return
-755.2%
Maximum drawdown
-67.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-9.1%-2.2%-6.9%-8.9%
7D-27.8%-12.7%-15.1%-27.1%
30D-24.8%-20.7%-4.1%-23.7%
3M-52.2%+46.3%-98.5%-53.1%
6M-49.7%+305.2%-354.9%-57.7%
YTD-61.3%+561.2%-622.5%-71.2%
1Y-57.6%+772.1%-829.7%-71.3%
All-57.6%+697.5%-755.2%-71.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling